MPR Weekly Dose Podcast #150

Kevzara approved for polymyalgia rheumatica; Skyclarys approved for Friedreich ataxia; Emergency authorization granted to at-home COVID-19, flu test; Drug-resistant bacteria spiking in the US; FDA clamps down on unlawful xylazine imports.